DC preparations for therapy

References

• Hart DNJ. Dendritic cells:unique leukocyte populations which control the primary immune response. Blood 1997;90:3245–87.
   PubMed Web of Science ®Google Scholar
• Hart DNJ. Dendritic cells and their emerging clinical applica-tions. Pathology 2001;33:478–91.
   Web of Science ®Google Scholar
• Clark GJ, Hart DNJ. Phenotypic characterization of dendritic cells. In: Lotze MT, Thomson AW editors. Dendritic cells. biology and clinical applications. USA: Academic Press, 1999:555— 77.
   Google Scholar
• Egner W, McKenzie JL, Smith SM et al. Identification of potentMLR stimulatory cells in human bone marrow. y Immunol 1993;150:3043.
   Google Scholar
• Reid C, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte— macrophage colony stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34 progenitors in human bone marrow. yImmunol 1992;149:2681— 8.
   Web of Science ®Google Scholar
• Young JW, Szabolcs P, Moore MA. Identification of dendritic cellcolony forming units among normal human CD34± bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of granulocyte/ macrophage colony stimulating factor and tumor necrosis factor-a. y Exp Med 1995;182: 1111–20.
   Google Scholar
• Caux C, Banchereau J. in vitro regulation of dendritic cell development and function. In: Whetton AD, Gordon J, editors. Blood cell chemisoy hematopoietic growth factors and their receptors. London: Plenum Press, 1996; Vol 7, 263— 301.
   Google Scholar
• Monji T, Petersons J, Saund NK et al. Competent dendritic cellsderived from CD34± progenitors express CMRF-44 antigen early in the differentiation pathway. Immunol Cell Biol 2002;80:216–25.
   PubMed Web of Science ®Google Scholar
• Santiago-Schwarz E Belilso E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macro-phages. y Leuk Biol 1992;52:274–81.
   Google Scholar
• Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258–61.
   PubMed Web of Science ®Google Scholar
• Santiago-Schwarz F; McCarthy M, Tucci J, Carsons SE. Neutralisation of rumor necrosis factor activity shortly after onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood 1998;92:745–55.
   PubMed Web of Science ®Google Scholar
• Santiago-Schwarz F; Divans N, Kay C. Mechanisms of TNF/ GM-CSF-induced dendritic cell development. Blood 1993;10:3019–28.
   Google Scholar
• Szabolcs P, Moore M, Young J. Expansion of immunostimulatorydendritic cells among myeloid progeny of human CD34 ± bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony stimulating factor and TNFa 7 Immunol 1995;154: 5851— 61.
   Google Scholar
• Siena S, DiNicola M, Bregni M et al. Massive ex vivo expansion offunctional dendritic cells from mobilised CD34 ± blood progeni-tors for anti cancer therapy. Exp Hematol 1995;23:1463— 71.
   PubMedGoogle Scholar
• Bykovskaja SN, Buffo MJ, Bunjer M et al. Interleukin-2 inducesdevelopment of dendritic cells from cord blood CD34± cells. Leuk Biol 1998;63:620— 30.
   PubMed Web of Science ®Google Scholar
• Traycoff CM, Kosak ST, Grigsby S, Srour EE Evaluation of exvivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 1995;85:2059–68.
   PubMed Web of Science ®Google Scholar
• Ratta M, Rondelli D, Fortuna A et al. Generation and functionalcharacterization of human dendritic cells derived from CD34 cells mobilised into peripheral blood: comparison with bone marrow CD34 ± cells. Br y Haematol 1998;101:756–65.
   PubMed Web of Science ®Google Scholar
• Wickenhauser C, Thiele J, Drebber U et al. CD34 ± humanhematopoietic progenitor cells of the bone marrow differ from those of the peripheral blood: an immunocytochemical and morphometric study. Acta Haematol 1995;93:83— 90.
   PubMed Web of Science ®Google Scholar
• Servida F; Soligo D, Lambertenghi Deliliers G. Functional differences between dendritic cells derived from CD34± bone marrow and peripheral blood stem cells. Haematologica 2000;85:352— 5.
   PubMed Web of Science ®Google Scholar
• Romani N, Gruner S, Brang D et al. Proliferating dendritic cellprogenitors in human blood. y Exp Med 1994;180:83–93.
   PubMed Web of Science ®Google Scholar
• Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. y Immunol Methods 1996;96:137–51.
   Google Scholar
• Zhou LJ, Tedder TE Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. y Immunol 1996;154:3821— 35.
   Google Scholar
• Peters JH, Giesler R, Thiele B, Steinbach E Dendritic cells: fromontogenetic orphans to myelomonocytic descendants. Immunol Today 1996;17:273–8.
   PubMedGoogle Scholar
• Sallusto R Lanzavecchia A. Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/ macrophage colony stimulating factor plus interleukin 4 and down regulated by tumour necrosis factor a. y Exp Med 1994;179:1109— 18.
   PubMed Web of Science ®Google Scholar
• Cella M, Sallusto F; Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10— 6.
   Google Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment down-regulation by cytokines and bacterial products. yExp Med 1995;182:389–400.
   PubMed Web of Science ®Google Scholar
• Kiertscher SM, Roth MD. Human CD14± leukocytes acquire the phenotype and function of antigen presenting dendritic cells when cultured in GM-CSF and IL-4. 7 Leuk Biol 1996;59: 208–18.
   Google Scholar
• Thurnher M, Zelle-Rieser C, Ramoner R et al. The disabled dendritic cell. FASEB y 2001;15:1054–61.
   PubMedGoogle Scholar
• Xu H, Kramer M, Spengler HP, Peters JH. Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. Adv Exp Med Biol 1995;378:75— 8.
   PubMedGoogle Scholar
• Luft T, Luetjens P, Hochrein H et al. IFN-alpha enhances CD40ligand-mediated activation of immature monocyte-derived den-dritic cells. Int Immunol 2002;14:367— 80.
   PubMed Web of Science ®Google Scholar
• Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients withB-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;21:52–8.
   Google Scholar
• Rice A, Hart D. Technology evaluation: APC 80200, Dendreon. Curr Opin Mol Ther 2002;4:523–7.
   PubMedGoogle Scholar
• Fearnley DB, McLellan AD, Mannering SI et al. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy. Blood 1997;89:3708— 16.
   PubMed Web of Science ®Google Scholar
• Hock BD, Fearnley DB, Boyce A et al. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens 1999;53:320— 34.
   PubMedGoogle Scholar
• Lopez JA, Crosbie G, Kelly C et al. Monitoring and isolation ofblood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy. 7 Immunol Methods 2002;267:199— 212.
   PubMed Web of Science ®Google Scholar
• Dzionek A, Fuchs A, Schmitz P et al. BDCA-2, BDCA-3 and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. y Immunol 2000;165:1646— 55.
   Google Scholar
• Luft T, Jefford M, Luetjens P et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002;100:1362–72.
   PubMed Web of Science ®Google Scholar
• Kato M, Neil TK, Fearnley DB et al. Expression of multilectinreceptors and comparative FITC dextran uptake by human dendritic cells. Jut Immunol 2000;12:1511–9.
   Google Scholar
• Osugi Y, Vuckovic S, Hart DN. Myeloid blood CD11c± dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002;100: 2858–66.
   Google Scholar
• Ho CSK, Munster D, Pyke CM et al. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002;99:2897–904.
   PubMed Web of Science ®Google Scholar
• Reichardt VL, Okada CY, Liso A et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma— a feasibility study. Blood 1999;93:2411–9.
   PubMed Web of Science ®Google Scholar
• Caux C, Massacrier C, Vanbervliet B et al. CD34± hemato-poietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony stimulating factor plus tumor necrosis factor-a: II functional analysis. Blood 1997;90:1458— 70.
   PubMed Web of Science ®Google Scholar
• Ferlazzo G, Wesa A, Wei WZ, Galy A. Dendritic cells generated either from CD34± progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8± T cells. ylmmunol 1999;163:3597— 604.
   PubMed Web of Science ®Google Scholar
• Meierhoff G, Krause S, Andreesen R. Comparative analysis of dendritic cells derived from blood monocytes or CD34± hematopoietic progenitor cells. Immunobiology 1998;198: 501–13.
   Google Scholar